vildagliptin, metformin (metformin hydrochloride) - risultati della ricerca

novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Unione Europea - italiano - EMA (European Medicines Agency)

xiliarx

novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

galvus 50 mg compresse

novartis pharma schweiz ag - vildagliptinum - compresse - vildagliptinum 50.0 mg, cellulosum microcristallinum, lactosum 47.82 mg, carboxymethylamylum natricum a corresp. natrium max. 0.3 mg, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika